![Immunohistochemistry-Paraffin: CCRL2/CRAM-A/B Antibody [NLS1093] - Human spleen tissue after heat-induced antigen retrieval.](http://images.novusbio.com/fullsize/CCRL2-CRAM-A-B-Antibody-Immunohistochemistry-Paraffin-NLS1093-img0007.jpg "Immunohistochemistry-Paraffin: CCRL2/CRAM-A/B Antibody [NLS1093] - Human spleen tissue after heat-induced antigen retrieval.")
| Reactivity | Hu, PmSpecies Glossary |
| Applications | IHC |
| Clonality | Polyclonal |
| Host | Rabbit |
| Conjugate | Unconjugated |
| Format | BSA Free |
| Concentration | 1.0 mg/ml |
| Description | Product can be stored undiluted at 4C for up to 1 month. |
| Immunogen | Synthetic 20 amino acid peptide from 2nd cytoplasmic domain of human CCRL2/CRAM-A/B. |
| Epitope | 2nd cytoplasmic domain |
| Specificity | Human CCRL2. BLAST analysis of the peptide immunogen showed no homology with other human proteins. |
| Isotype | IgG |
| Clonality | Polyclonal |
| Host | Rabbit |
| Gene | CCRL2 |
| Purity | Immunogen affinity purified |
| Innovator's Reward | Test in a species/application not listed above to receive a full credit towards a future purchase. |
| Storage | Keep as concentrated solution. Aliquot and store at -20C or below. Avoid multiple freeze-thaw cycles. |
| Buffer | PBS |
| Preservative | 0.1% Sodium Azide |
| Concentration | 1.0 mg/ml |
| Purity | Immunogen affinity purified |
![Immunocytochemistry CCR7 Antibody (150503) [Unconjugated]](https://images.novusbio.com/images2/CCR7_MAB197_Immunocytochemistry_6580.jpg)
![Immunohistochemistry CCR7 Antibody (150503) [Unconjugated]](https://images.novusbio.com/images2/CCR7_MAB197_Immunohistochemistry_22800.jpg)
![Neutralization CCR7 Antibody (150503) [Unconjugated]](https://images.novusbio.com/images2/CCR7_MAB197_Block_Neutralize_9048.jpg)
Secondary Antibodies |
Isotype Controls |
Research Areas for CCRL2/CRAM-A/B Antibody (NLS1093)Find related products by research area.
|
The concentration calculator allows you to quickly calculate the volume, mass or concentration of your vial. Simply enter your mass, volume, or concentration values for your reagent and the calculator will determine the rest.
![Immunohistochemistry-Paraffin: CCRL2/CRAM-A/B Antibody [NLS1093] - Analysis of anti-CCRL2 antibody with human lymph node, Hodgkins lymphoma.](http://images.novusbio.com/fullsize/CCRL2-CRAM-A-B-Antibody-Immunohistochemistry-Paraffin-NLS1093-img0005.jpg "Immunohistochemistry-Paraffin: CCRL2/CRAM-A/B Antibody [NLS1093] - Analysis of anti-CCRL2 antibody with human lymph node, Hodgkins lymphoma.")
![Immunohistochemistry-Paraffin: CCRL2/CRAM-A/B Antibody [NLS1093] - Human Ovary, Carcinoma tissue after heat-induced antigen retrieval.](http://images.novusbio.com/fullsize/CCRL2-CRAM-A-B-Antibody-Immunohistochemistry-NLS1093-img0006.jpg "Immunohistochemistry-Paraffin: CCRL2/CRAM-A/B Antibody [NLS1093] - Human Ovary, Carcinoma tissue after heat-induced antigen retrieval.")
![N/A CCL20/MIP-3 alpha [HRP]](https://images.novusbio.com/images2/DATA_CCL20_DM3A00_ELISA_752.jpg)
![N/A CCL20/MIP-3 alpha [HRP]](https://images.novusbio.com/images2/DATA_CCL20_DM3A00_ELISA_753.jpg)
![N/A CCL20/MIP-3 alpha [HRP]](https://images.novusbio.com/images2/CCL20_DM3A00_ELISA_137.jpg)
![N/A IL-17/IL-17A [Biotin]](https://images.novusbio.com/images2/DATA_IL17_DY421_ELISA_2448.jpg)
![SDS-PAGE TNF-alpha [Unconjugated]](https://images.novusbio.com/images2/TNF-alpha_210-TA_256.jpg)
![Bioactivity TNF-alpha [Unconjugated]](https://images.novusbio.com/images2/TNFalpha_210TA_1658.jpg)
![SEC-MALS TNF-alpha [Unconjugated]](https://images.novusbio.com/images/210-ta_recombinant-human-tnf-alpha-protein-sec-mals-35202312244..jpg)
![Flow Cytometry CCR5 Antibody (45531) [Unconjugated]](https://images.novusbio.com/images2/CCR5_MAB182_Flow_Cytometry_22407.jpg)
![Neutralization CCR5 Antibody (45531) [Unconjugated]](https://images.novusbio.com/images2/CCR5_MAB182_Block_Neutralize_9044.jpg)
![Immunocytochemistry CCR5 Antibody (45531) [Unconjugated]](https://images.novusbio.com/images2/CCR5_MAB182_Immunocytochemistry_9681.jpg)
![Flow Cytometry CXCR3 Antibody (49801) [Unconjugated]](https://images.novusbio.com/images2/CXCR3_MAB160_Flow_Cytometry_22088.jpg)
![Flow Cytometry CXCR3 Antibody (49801) [Unconjugated]](https://images.novusbio.com/images2/CXCR3_MAB160_Flow_Cytometry_22089.jpg)
![Neutralization CXCR3 Antibody (49801) [Unconjugated]](https://images.novusbio.com/images2/CXCR3_MAB160_Block_Neutralize_9031.jpg)
![SDS-PAGE IL-22 [Unconjugated]](https://images.novusbio.com/images2/IL-22_782-IL_CF_734.jpg)
![Bioactivity IL-22 [Unconjugated]](https://images.novusbio.com/images2/IL-22_782-IL_CF_743.jpg)
![Flow Cytometry CCR4 Antibody (205410) [Unconjugated]](https://images.novusbio.com/images2/CCR4_MAB1567_Flow_Cytometry_20627.jpg)
![Immunohistochemistry CXCR4 Antibody (44716) [Unconjugated]](https://images.novusbio.com/images2/CXCR4_MAB172_Immunohistochemistry_6955.jpg)
![Neutralization CXCR4 Antibody (44716) [Unconjugated]](https://images.novusbio.com/images2/CXCR4_MAB172_Block_Neutralize_9041.jpg)
![Immunohistochemistry CXCR4 Antibody (44716) [Unconjugated]](https://images.novusbio.com/images2/CXCR4_MAB172_Immunohistochemistry_19917.jpg)
![Immunohistochemistry CCR2 Antibody (48607) [Unconjugated]](https://images.novusbio.com/images2/CCR2_MAB150_Immunohistochemistry_18879.jpg)
![Flow Cytometry CCR2 Antibody (48607) [Unconjugated]](https://images.novusbio.com/images2/CCR2_MAB150_Flow_Cytometry_19981.jpg)
![N/A IL-6 [HRP]](https://images.novusbio.com/images2/DATA_IL6_M6000_ELISA_936.jpg)
![N/A IL-6 [HRP]](https://images.novusbio.com/images2/IL-6_M6000_ELISA_415.jpg)
![N/A IL-6 [HRP]](https://images.novusbio.com/images/m6000b_mouse-il-6-quantikine-elisa-kit-44202415433118.jpg)
![Flow Cytometry CC Chemokine Receptor D6 Antibody (196124) [Unconjugated]](https://images.novusbio.com/images2/D6_MAB1364_Flow_Cytometry_15842.jpg)
![Bioactivity IL-4 [Unconjugated]](https://images.novusbio.com/images/protein/6507-ilcf_recombinant-human-il-4-cho-expressed-protein-cf-bioactivity-272020133214.jpg)
![N/A CCL5/RANTES [HRP]](https://images.novusbio.com/images2/CCL5_DRN00_ELISA_393.jpg)
![N/A CCL5/RANTES [HRP]](https://images.novusbio.com/images2/DATA_CCL5_DRN00_ELISA_810.jpg)
![N/A CCL5/RANTES [HRP]](https://images.novusbio.com/images2/DATA_CCL5_DRN00_ELISA_811.jpg)
![Western Blot: Goat anti-Rabbit IgG (H+L) Secondary Antibody [HRP] [NB7160] - Western blot showing vemurafenib treatment in BRAFV600E CRC cells inhibits fission mediator DRP1 with no significant effect on fusion proteins (Mfn1 & 2) using MFN-1 antibody (NBP1-51841) and corresponding secondary antibody, goat anti-rabbit IgG-HRP (NB7160). Image collected and cropped by CiteAb from the following publication (https://pubmed.ncbi.nlm.nih.gov/33738242).](https://images.novusbio.com/images/Goat-anti-Rabbit-IgG-H+L-Secondary-Antibody-HRP-Western-Blot-NB7160-img0001.jpg "Western Blot: Goat anti-Rabbit IgG (H+L) Secondary Antibody [HRP] [NB7160] - Western blot showing vemurafenib treatment in BRAFV600E CRC cells inhibits fission mediator DRP1 with no significant effect on fusion proteins (Mfn1 & 2) using MFN-1 antibody (NBP1-51841) and corresponding secondary antibody, goat anti-rabbit IgG-HRP (NB7160). Image collected and cropped by CiteAb from the following publication (https://pubmed.ncbi.nlm.nih.gov/33738242).")
![Flow Cytometry: Rabbit IgG Isotype Control [NBP2-24891] - Intracellular FACS analysis of mouse TLR6 polyclonal antibody (red), rabbit isotype control (green), RAW cells alone (shaded). Two micrograms of antibodies were used. Goat anti-rabbit FITC (Novus, 20302) was used as secondary.](https://images.novusbio.com/images/Rabbit--Mouse-IgG-Isotype-Control-Flow-Cytometry-NBP2-24891-img0001.jpg "Flow Cytometry: Rabbit IgG Isotype Control [NBP2-24891] - Intracellular FACS analysis of mouse TLR6 polyclonal antibody (red), rabbit isotype control (green), RAW cells alone (shaded). Two micrograms of antibodies were used. Goat anti-rabbit FITC (Novus, 20302) was used as secondary.")